Clinical trial
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
NCT00071448
Study timeline
Study start (unknown)2002-06-01Date precision: month
Registry last updated2016-12-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetesunresolved
Diabetes Mellitus, Type 1unresolved
Interventions
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
New YorkNew York, United States2BostonMassachusetts, United States2BaltimoreMaryland, United States2San AntonioTexas, United States2San DiegoCalifornia, United States2IndianapolisIndiana, United States2OmahaNebraska, United States2MemphisTennessee, United States2GainesvilleFlorida, United States2Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00071448 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.